Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-07-14 12:40:26

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-07-09 10:41:34

IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.

zacks.com - 2026-07-03 09:55:46

TORONTO--(BUSINESS WIRE)--StackAdapt (www.stackadapt.com), the leading AI advertising and orchestration platform, today announced a collaboration with IQVIA Digital to advance more relevant and compliant engagement with healthcare audiences. IQVIA Digital's integrated solutions enable marketers to quickly transform data-driven insights into meaningful, privacy-conscious activation across the healthcare ecosystem.Through this collaboration, StackAdapt's programmatic advertising capabilities are n.

businesswire.com - 2026-06-18 10:17:00

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

forbes.com - 2026-06-17 12:30:08

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-17 10:40:16

Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.

247wallst.com - 2026-06-17 08:00:44

IQVIA Holdings gains from its vast healthcare data, AI-driven analytics & global IT infrastructure, supporting expansion and solid growth.

zacks.com - 2026-06-15 12:17:31

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-15 10:50:44

Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released [url="]Scientific Discovery and AI: The Science-to-Patient Journey[/url], a cross-sector intelligence repo

gurufocus.com - 2026-06-15 10:00:00

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies. The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The sessi.

businesswire.com - 2026-06-15 09:00:00

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:36:32

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer's existing indebtedness and to pay fees and expenses related to the Notes offering. The Notes will bear interest at a rate of 4.625% per annum a.

businesswire.com - 2026-06-04 10:51:00

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-03 11:22:05

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 t

gurufocus.com - 2026-06-03 03:00:00

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 through an offering of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer's existing indebtedness and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other custo.

businesswire.com - 2026-06-03 02:53:00

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-01 10:42:30

VEEV and IQV are benefiting from life sciences digitization trends, but differences in growth, AI adoption and valuation set them apart.

zacks.com - 2026-05-29 12:16:06

IQVIA's record $34.2B backlog, AI-led pharma demand and $1.24B buybacks support growth despite weak liquidity and no dividend.

zacks.com - 2026-05-27 13:01:21

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-05-26 10:51:15

IQVIA earns a Buy rating as the market underappreciates its AI-driven Commercial Solutions segment and unique healthcare data assets. AI is a tailwind, not a threat, with 19 of the top 20 pharma companies using IQV's AI agents and workflows. Commercial Solutions segment grew 11.6% year-over-year, outpacing the traditional CRO segment and driving margin expansion.

seekingalpha.com - 2026-05-20 12:05:32

Our top-performing stocks this quarter were Samsung Electronics, Shell and Lam Research. Our worst contributors were IQVIA, American Express and Heidelberg. We exited our investments in Everest Group and PayPal during the quarter.

seekingalpha.com - 2026-05-19 08:40:00

Valvoline was Broyhill's largest contributor in the quarter, as the underlying unit economics are intact, while unit growth, service mix, and price continue moving in the same direction. Honeywell management accelerated the aerospace spin-off to the end of June, leaving behind a pure-play automation business that Broyhill believes is worth meaningfully more than the whole. Large pharma is structurally reliant on IQVIA's clinical trial architecture and proprietary data assets, and Broyhill thinks it is highly unlikely that AI can automate away the FDA approval process.

seekingalpha.com - 2026-05-15 02:55:00

IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 16:40:48

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-05-12 10:41:24

IQVIA NYSE: IQV reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing accelerating organic growth across its Commercial Solutions and R&D Solutions businesses, increased demand tied to artificial intelligence offerings and continued strength in forward-looking clinical development metrics.

marketbeat.com - 2026-05-11 00:06:14

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-05-06 10:30:38

We initiated four new positions in Q1, an above-average pace of activity. We also used the increased volatility to upgrade overall portfolio quality. Our three largest new positions were Amazon.com, Universal Music Group and IQVIA Holdings. In addition to sales of Humana and PayPal, we also exited our positions in social technology leader Meta Platforms and beverages company Diageo.

seekingalpha.com - 2026-05-06 00:34:00

IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-05 16:31:27

IQVIA tops on Q1 EPS and revenues on strong Commercial Solutions growth, lifts its 2026 EPS outlook and keeps the revenue & EBITDA guidance steady.

zacks.com - 2026-05-05 13:55:17

IQVIA Holdings (IQV) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.83 per share. This compares to earnings of $2.7 per share a year ago.

zacks.com - 2026-05-05 09:26:20

IQV heads into Q1 earnings release with steady growth expectations, driven by AI-backed solutions, strong bookings and rising pharma demand.

zacks.com - 2026-05-04 13:36:16

Veeva Systems sits at the intersection of life sciences and enterprise cloud computing.

fool.com - 2026-05-04 09:00:00

D.A. Davidson and CO. increased its position in IQVIA Holdings Inc. (NYSE: IQV) by 25.4% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,190 shares of the medical research company's stock after acquiring an additional 5,514 shares during the quarter.

defenseworld.net - 2026-04-29 15:13:21

Concurrent Investment Advisors LLC lifted its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 36.0% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,948 shares of the medical research company's stock after purchasing an additional

defenseworld.net - 2026-04-29 14:10:57

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:00:52

Arizona State Retirement System reduced its position in IQVIA Holdings Inc. (NYSE: IQV) by 8.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,683 shares of the medical research company's stock after selling 4,548 shares during the quarter.

defenseworld.net - 2026-04-26 03:08:53

Calamos Wealth Management LLC acquired a new position in IQVIA Holdings Inc. (NYSE: IQV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 52,910 shares of the medical research company's stock, valued at approximately $11,926,000. Several other institutional investors and hedge funds

defenseworld.net - 2026-04-25 04:30:43

Calamos Advisors LLC boosted its holdings in IQVIA Holdings Inc. (NYSE: IQV) by 268.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 188,707 shares of the medical research company's stock after acquiring an additional 137,441 shares during the period. Calamos Advisors LLC owned

defenseworld.net - 2026-04-25 03:56:55

Mirae Asset Global Investments Co. Ltd. increased its position in IQVIA Holdings Inc. (NYSE: IQV) by 27.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,220 shares of the medical research company's stock after acquiring an additional 8,765 shares during the

defenseworld.net - 2026-04-20 05:16:56

On April 16, 2026, IQVIA Holdings Inc (IQV) shares fell 3.5% today, bringing the current price to $171.95. Over the past 52 weeks, the stock has fluctuated betw

gurufocus.com - 2026-04-16 17:24:00

Artisan Mid Cap Value Fund portfolio trailed the Russell Midcap® Value Index in Q1. Performance was weighed down by a market environment that continued to favor momentum-driven stocks, with less support for quality factors. Among the biggest decliners were ICON, Gartner and Pinterest, each of which dropped by 30% or more during the quarter. Our three largest new buys by position size were Brown & Brown, Veralto and IQVIA Holdings.

seekingalpha.com - 2026-04-15 09:21:00

Assetmark Inc. grew its position in IQVIA Holdings Inc. (NYSE: IQV) by 33.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 172,625 shares of the medical research company's stock after acquiring an additional 43,436 shares during the quarter.

defenseworld.net - 2026-04-15 03:19:33